J 2022

Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

OBERMANNOVÁ, Radka, M. ALSINA, A. CERVANTES, T. LEONG, F. LORDICK et. al.

Basic information

Original name

Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Authors

OBERMANNOVÁ, Radka (203 Czech Republic, guarantor, belonging to the institution), M. ALSINA, A. CERVANTES, T. LEONG, F. LORDICK, M. NILSSON, N. C. T. VAN GRIEKEN, A. VOGEL and E. C. SMYTH

Edition

Annals of Oncology, AMSTERDAM, Elsevier, 2022, 0923-7534

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30204 Oncology

Country of publisher

Netherlands

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 50.500

RIV identification code

RIV/00216224:14110/22:00128842

Organization unit

Faculty of Medicine

UT WoS

000938788800003

Keywords in English

diagnosis; ESMO Clinical Practice Guideline; follow-up; oesophageal cancer; treatment

Tags

Tags

International impact, Reviewed
Změněno: 5/4/2023 08:44, Mgr. Tereza Miškechová

Abstract

V originále

This ESMO Clinical Practice Guideline provides key recommendations for managing oesophageal cancer. • The guideline covers clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up. • Algorithms for the management of locoregional and advanced/metastatic disease are provided. • The author group encompasses a multidisciplinary group of experts from different institutions in Europe and Australia. • Recommendations are based on available scientific data and the authors’ collective expert opinion.